Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

Consumer Product Partners, LLC

US Class II Ongoing · initiated 2025-05-23

Subpotent product: Product has cloudy appearance and tested below assay label claim for 70% Ethyl Alcohol

Ascend Laboratories, LLC

US Class II Ongoing · initiated 2025-05-23

Failed Impurities/Degradation Specifications An out-of-specification result was observed in the related substance test at the sixth month of stability analysis.…

Ascend Laboratories, LLC

US Class II Ongoing · initiated 2025-05-23

Failed Impurities/Degradation Specifications An out-of-specification result was observed in the related substance test at the sixth month of stability analysis.…

Teva Pharmaceuticals USA, Inc

US Class II Ongoing · initiated 2025-05-23

Presence of foreign tablets/capsules.

Aurobindo Pharma USA Inc

US Class II Ongoing · initiated 2025-05-22

cGMP deviations: Due to confirmed consumer complaints received with the observation of tablet discoloration (brown surface on tablets).

TARO-GLICLAZIDE MR

Canada Type II Ongoing · initiated 2025-05-22

Product safety. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health con…

Umary-USA.com

US Class I Completed · initiated 2025-05-21

Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone, Diclofenac and Omeprazole.

Umary-USA.com

US Class I Completed · initiated 2025-05-21

Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone and Diclofenac.

Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)

US Class II Ongoing · initiated 2025-05-21

Lack of Assurance of Sterility

Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)

US Class II Ongoing · initiated 2025-05-21

Lack of Assurance of Sterility

Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)

US Class II Ongoing · initiated 2025-05-21

Lack of Assurance of Sterility

Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)

US Class II Ongoing · initiated 2025-05-21

Lack of Assurance of Sterility

Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)

US Class II Ongoing · initiated 2025-05-21

Lack of Assurance of Sterility

Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)

US Class II Ongoing · initiated 2025-05-21

Lack of Assurance of Sterility

Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)

US Class II Ongoing · initiated 2025-05-21

Lack of Assurance of Sterility

Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)

US Class II Ongoing · initiated 2025-05-21

Lack of Assurance of Sterility

Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)

US Class II Ongoing · initiated 2025-05-21

Lack of Assurance of Sterility

Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)

US Class II Ongoing · initiated 2025-05-21

Lack of Assurance of Sterility

Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)

US Class II Ongoing · initiated 2025-05-21

Lack of Assurance of Sterility

Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)

US Class II Ongoing · initiated 2025-05-21

Lack of Assurance of Sterility

Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)

US Class II Ongoing · initiated 2025-05-21

Lack of Assurance of Sterility

Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)

US Class II Ongoing · initiated 2025-05-21

Lack of Assurance of Sterility

Glenmark Pharmaceuticals Inc., USA

US Class III Ongoing · initiated 2025-05-19

Failed Impurities/Degradation Specifications: Out of Specification (OOS) for related substances test for Anhydro Simvastatin at the 06-month time point during l…

ALLEVIATE Relief Stick

Canada Type II Ongoing · initiated 2025-05-16

Product safety. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health con…

CareFusion 213, LLC

US Class II Ongoing · initiated 2025-05-15

Lack of Assurance of Sterility: The affected product may exhibit an open seal on the packaging of the applicator.